Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Wendy Armstrong

Concepts (357)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
63
2024
2729
6.090
Why?
Epidemics
6
2024
82
2.160
Why?
Communicable Diseases
8
2023
152
1.960
Why?
Anti-Retroviral Agents
5
2019
231
1.750
Why?
Anti-HIV Agents
13
2024
757
1.630
Why?
Viral Load
13
2023
449
1.200
Why?
Infectious Disease Medicine
2
2017
12
1.120
Why?
Continuity of Patient Care
5
2022
276
1.030
Why?
Internal Medicine
3
2016
245
0.950
Why?
Social Stigma
2
2024
116
0.940
Why?
AIDS-Related Opportunistic Infections
5
2019
123
0.940
Why?
HIV
13
2023
227
0.930
Why?
Drug Monitoring
2
2016
214
0.800
Why?
Immune Reconstitution Inflammatory Syndrome
2
2019
18
0.790
Why?
Internship and Residency
6
2021
1049
0.780
Why?
Pre-Exposure Prophylaxis
3
2024
205
0.730
Why?
Adenine
2
2020
257
0.680
Why?
Antiretroviral Therapy, Highly Active
6
2019
267
0.670
Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2020
17
0.660
Why?
Diagnostic Tests, Routine
2
2021
103
0.640
Why?
Acquired Immunodeficiency Syndrome
7
2022
228
0.630
Why?
Humans
91
2024
129527
0.620
Why?
Consumer Advocacy
1
2018
12
0.600
Why?
Health Services Accessibility
4
2024
897
0.590
Why?
Career Choice
3
2018
206
0.590
Why?
Lost to Follow-Up
2
2017
21
0.580
Why?
United States
25
2024
13865
0.580
Why?
Health Policy
3
2023
350
0.550
Why?
Delivery of Health Care
4
2021
896
0.540
Why?
Substance-Related Disorders
6
2021
1022
0.520
Why?
CD4 Lymphocyte Count
6
2020
267
0.520
Why?
Georgia
10
2024
80
0.500
Why?
Medication Adherence
2
2017
560
0.480
Why?
Antimicrobial Stewardship
3
2023
107
0.480
Why?
Disease Management
1
2019
591
0.470
Why?
HIV-Associated Lipodystrophy Syndrome
1
2014
12
0.460
Why?
Biomedical Research
2
2018
639
0.450
Why?
Urban Population
1
2017
442
0.440
Why?
Bone Diseases
1
2014
57
0.430
Why?
Financing, Government
1
2014
43
0.430
Why?
HIV-1
5
2016
839
0.430
Why?
Patient Acceptance of Health Care
2
2017
761
0.430
Why?
Metabolic Diseases
1
2014
103
0.420
Why?
Rural Population
1
2017
520
0.410
Why?
Drug Resistance, Viral
2
2005
110
0.410
Why?
Ventriculostomy
1
2012
21
0.380
Why?
Chronic Pain
3
2021
253
0.380
Why?
Ambulatory Care
2
2021
507
0.370
Why?
Medication Errors
1
2012
96
0.370
Why?
Mycoses
1
2012
73
0.360
Why?
Critical Care
1
2016
552
0.360
Why?
Central Nervous System Diseases
1
2012
68
0.360
Why?
Prostheses and Implants
1
2012
132
0.350
Why?
Disease Transmission, Infectious
1
2011
55
0.340
Why?
Gram-Positive Bacterial Infections
2
2008
64
0.340
Why?
Analgesics, Opioid
5
2021
919
0.340
Why?
Cellulitis
2
2011
49
0.330
Why?
Bacterial Infections
1
2012
234
0.330
Why?
Microbiology
3
2014
24
0.330
Why?
Physicians
5
2019
872
0.330
Why?
Global Health
2
2018
328
0.310
Why?
Male
39
2024
63586
0.310
Why?
Dermatitis
1
2008
19
0.310
Why?
Female
40
2024
68650
0.310
Why?
Patient-Centered Care
1
2014
501
0.300
Why?
Adult
32
2024
35505
0.300
Why?
Medical Informatics
1
2009
99
0.300
Why?
Education, Medical, Graduate
5
2023
439
0.300
Why?
Gram-Negative Bacterial Infections
1
2008
45
0.300
Why?
Middle Aged
31
2024
31087
0.290
Why?
Information Dissemination
1
2009
204
0.280
Why?
Africa, Eastern
2
2017
12
0.280
Why?
AIDS Vaccines
2
2005
47
0.280
Why?
Periodicals as Topic
1
2009
204
0.270
Why?
Internet
2
2014
620
0.260
Why?
Developing Countries
3
2017
282
0.260
Why?
Pneumonia, Pneumocystis
4
2015
36
0.260
Why?
Curriculum
5
2023
922
0.250
Why?
Mycobacterium chelonae
1
2005
8
0.250
Why?
Databases, Factual
2
2019
1261
0.250
Why?
Rilpivirine
1
2024
7
0.230
Why?
Fellowships and Scholarships
4
2023
278
0.220
Why?
Skin
1
2008
724
0.220
Why?
Interviews as Topic
2
2017
707
0.210
Why?
Cost-Benefit Analysis
3
2021
566
0.210
Why?
Meningoencephalitis
1
2003
25
0.210
Why?
West Nile virus
1
2003
40
0.210
Why?
Pyridones
1
2024
158
0.200
Why?
Practice Guidelines as Topic
3
2019
1510
0.200
Why?
Pain Management
3
2021
330
0.200
Why?
Bacteria
1
2008
812
0.190
Why?
Simulation Training
1
2023
82
0.190
Why?
Anti-Infective Agents
3
2015
249
0.190
Why?
Coronary Artery Bypass
1
2003
224
0.190
Why?
Erythrocyte Transfusion
1
2003
182
0.180
Why?
Mass Screening
2
2020
1186
0.180
Why?
Colony-Stimulating Factors
1
2001
35
0.180
Why?
Obesity
1
2014
2875
0.180
Why?
Registries
2
2019
1902
0.180
Why?
Contact Tracing
1
2020
24
0.180
Why?
Sexual and Gender Minorities
1
2024
196
0.170
Why?
Mycobacterium Infections, Nontuberculous
1
2005
353
0.170
Why?
Prescription Drug Misuse
1
2021
40
0.170
Why?
Cities
4
2022
105
0.170
Why?
Erythropoietin
1
2001
88
0.170
Why?
Models, Theoretical
2
2021
548
0.170
Why?
Life Expectancy
1
2020
61
0.160
Why?
Health Equity
1
2021
87
0.160
Why?
Cross-Sectional Studies
5
2021
5078
0.160
Why?
Policy
1
2021
143
0.160
Why?
Interleukin-2
1
2001
437
0.160
Why?
Alanine
1
2020
143
0.160
Why?
Fever of Unknown Origin
1
1999
10
0.150
Why?
Heart Diseases
1
2022
349
0.150
Why?
Mentors
2
2018
175
0.150
Why?
Leukoencephalopathy, Progressive Multifocal
1
2019
37
0.150
Why?
Prevalence
5
2024
2561
0.150
Why?
Comorbidity
2
2020
1548
0.150
Why?
Tenofovir
1
2020
232
0.150
Why?
Pandemics
3
2021
1500
0.150
Why?
Microbial Sensitivity Tests
3
2016
349
0.150
Why?
Hospitalization
4
2020
2076
0.140
Why?
Cohort Studies
6
2019
5423
0.140
Why?
Physician Assistants
1
2019
89
0.140
Why?
Anti-Bacterial Agents
4
2011
1708
0.140
Why?
Capital Financing
1
2017
7
0.140
Why?
Patient Identification Systems
1
2017
16
0.140
Why?
Sustained Virologic Response
1
2017
37
0.140
Why?
Africa
1
2017
99
0.140
Why?
Nurse Practitioners
1
2019
133
0.140
Why?
Research Personnel
1
2018
156
0.130
Why?
Viral Tropism
1
2016
29
0.130
Why?
Financing, Personal
1
2016
26
0.130
Why?
Opioid-Related Disorders
2
2021
484
0.130
Why?
Case Management
1
2016
63
0.130
Why?
Risk Factors
6
2019
9779
0.120
Why?
Motivation
2
2017
547
0.120
Why?
Hospitals
2
2021
649
0.120
Why?
Pneumonia, Viral
1
2020
342
0.120
Why?
Coronavirus Infections
1
2020
336
0.120
Why?
Drug Utilization Review
1
2015
55
0.120
Why?
Time-to-Treatment
1
2017
178
0.120
Why?
Organizational Policy
1
2015
78
0.120
Why?
Patient Navigation
1
2016
78
0.120
Why?
HIV Protease Inhibitors
1
2015
68
0.120
Why?
Esophageal Diseases
1
2015
27
0.120
Why?
Online Systems
1
2014
22
0.120
Why?
Candidiasis
1
2015
57
0.120
Why?
Pregnancy Complications, Infectious
1
2019
367
0.120
Why?
Cytosol
1
2015
219
0.110
Why?
Healthcare Disparities
1
2020
579
0.110
Why?
Alcoholism
1
2021
764
0.110
Why?
Organophosphates
1
2015
122
0.110
Why?
Ambulatory Care Facilities
1
2016
228
0.110
Why?
Drug Interactions
1
2015
397
0.110
Why?
Patient Readmission
1
2019
667
0.100
Why?
DNA, Viral
2
2012
347
0.100
Why?
Telemedicine
1
2021
792
0.100
Why?
Aged
8
2022
22063
0.100
Why?
Health Plan Implementation
1
2014
136
0.100
Why?
Dihydropteroate Synthase
2
2004
3
0.100
Why?
Pilot Projects
2
2017
1594
0.100
Why?
Incidence
2
2021
2643
0.100
Why?
Retrospective Studies
7
2022
14532
0.100
Why?
Medication Reconciliation
1
2012
29
0.100
Why?
Myocardial Infarction
2
2019
1018
0.100
Why?
Leukocytes, Mononuclear
1
2015
546
0.100
Why?
Longitudinal Studies
2
2019
2724
0.100
Why?
Oligopeptides
1
2014
260
0.100
Why?
HIV Antibodies
1
2012
57
0.100
Why?
Socioeconomic Factors
2
2020
1211
0.090
Why?
Primary Health Care
2
2019
1677
0.090
Why?
Mycobacterium haemophilum
1
2011
1
0.090
Why?
Electronic Health Records
1
2019
977
0.090
Why?
Catheter-Related Infections
1
2012
72
0.090
Why?
Parasitic Diseases
1
2011
8
0.090
Why?
Research
1
2014
419
0.090
Why?
Cytomegalovirus
1
2012
154
0.090
Why?
Health Care Costs
1
2014
366
0.090
Why?
Pneumocystis
2
2001
11
0.090
Why?
Mycobacterium Infections
1
2011
62
0.090
Why?
Simian Immunodeficiency Virus
1
2011
86
0.090
Why?
Surveys and Questionnaires
5
2023
5429
0.090
Why?
Simian Acquired Immunodeficiency Syndrome
1
2011
84
0.090
Why?
Education, Medical, Undergraduate
1
2013
179
0.090
Why?
Pyridines
1
2014
478
0.080
Why?
Sulfonamides
1
2014
497
0.080
Why?
Geography
1
2011
189
0.080
Why?
Cytomegalovirus Infections
1
2012
190
0.080
Why?
Deep Brain Stimulation
1
2012
125
0.080
Why?
Rectum
1
2011
170
0.080
Why?
Antibodies, Neutralizing
1
2012
265
0.080
Why?
Desiccation
1
2009
20
0.080
Why?
Colon
1
2011
257
0.080
Why?
Emigrants and Immigrants
1
2011
122
0.080
Why?
Education, Medical, Continuing
1
2009
121
0.070
Why?
Drug Therapy, Combination
3
2014
1037
0.070
Why?
Syphilis, Cutaneous
1
2007
3
0.070
Why?
Immunoglobulin G
1
2012
851
0.070
Why?
Specimen Handling
1
2009
163
0.070
Why?
Dendritic Cells
1
2011
481
0.070
Why?
Adolescent
4
2021
20409
0.070
Why?
Plasma
1
2009
206
0.070
Why?
Hepacivirus
1
2009
242
0.070
Why?
Treatment Outcome
6
2024
10232
0.070
Why?
Risk Assessment
3
2019
3255
0.070
Why?
B-Lymphocytes
1
2012
816
0.070
Why?
Hepatitis C
1
2009
244
0.060
Why?
HIV-2
1
2005
18
0.060
Why?
CD4-Positive T-Lymphocytes
1
2011
1058
0.060
Why?
Diagnosis, Differential
2
2007
1422
0.060
Why?
Sex Factors
1
2011
1966
0.060
Why?
Dapsone
2
2004
7
0.060
Why?
Patient Education as Topic
1
2009
738
0.060
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2004
38
0.060
Why?
Chronic Disease
2
2012
1722
0.060
Why?
Pneumocystis carinii
1
2004
11
0.060
Why?
Virulence
1
2005
255
0.050
Why?
Mediastinitis
1
2003
3
0.050
Why?
Vancomycin Resistance
1
2003
14
0.050
Why?
Young Adult
2
2021
12438
0.050
Why?
Enterococcus faecium
1
2003
14
0.050
Why?
Delayed-Action Preparations
1
2024
172
0.050
Why?
Wound Healing
1
2005
308
0.050
Why?
Fatal Outcome
1
2003
300
0.050
Why?
Liver Failure
1
2002
91
0.050
Why?
Biopsy
1
2005
1087
0.050
Why?
Cryptococcosis
1
2001
26
0.050
Why?
Adipose Tissue
1
2005
594
0.050
Why?
Transplantation, Homologous
1
2002
402
0.050
Why?
Dental Care
1
2021
25
0.050
Why?
Mutation
2
2004
3702
0.050
Why?
Time Factors
3
2019
6530
0.050
Why?
Intracranial Hypertension
1
2001
37
0.050
Why?
Coronary Disease
2
2003
380
0.040
Why?
Blood
2
2012
105
0.040
Why?
Naphthoquinones
1
2001
19
0.040
Why?
Cytochrome b Group
1
2001
18
0.040
Why?
Quality-Adjusted Life Years
1
2021
106
0.040
Why?
Renal Insufficiency
1
2002
149
0.040
Why?
Patient Outcome Assessment
1
2021
126
0.040
Why?
Trust
1
2021
116
0.040
Why?
Meningitis
1
2001
79
0.040
Why?
Prospective Studies
1
2012
7150
0.040
Why?
Neutropenia
1
2001
137
0.040
Why?
Antifungal Agents
1
2001
130
0.040
Why?
Personal Satisfaction
1
2021
204
0.040
Why?
Anemia
1
2001
161
0.040
Why?
JC Virus
1
2019
23
0.040
Why?
Antiviral Agents
1
2005
719
0.040
Why?
Spinal Diseases
1
1999
47
0.040
Why?
Asymptomatic Infections
1
2019
26
0.040
Why?
Polyomavirus Infections
1
2019
28
0.040
Why?
Boston
1
2019
89
0.040
Why?
Esophageal Stenosis
1
1999
51
0.040
Why?
Polymerase Chain Reaction
3
2011
1031
0.040
Why?
Insurance, Health
1
2021
269
0.040
Why?
Abscess
1
1999
73
0.040
Why?
Health Status Disparities
1
2021
256
0.040
Why?
Training Support
1
2018
28
0.040
Why?
Benchmarking
1
2019
175
0.040
Why?
Preceptorship
1
2018
63
0.040
Why?
Substance Abuse Detection
1
2019
79
0.040
Why?
Multicenter Studies as Topic
1
2019
287
0.040
Why?
Recombinant Proteins
1
2001
1311
0.030
Why?
Heart-Assist Devices
1
2003
538
0.030
Why?
Patient Satisfaction
1
2021
636
0.030
Why?
Dyslipidemias
1
2019
173
0.030
Why?
Hospitals, Public
1
2017
26
0.030
Why?
Drug Administration Schedule
1
2019
763
0.030
Why?
Medicare
1
2022
716
0.030
Why?
Prenatal Care
1
2019
277
0.030
Why?
Odds Ratio
1
2019
1018
0.030
Why?
Needs Assessment
1
2018
355
0.030
Why?
Postpartum Period
1
2019
328
0.030
Why?
Public Health Surveillance
1
2016
68
0.030
Why?
Delayed Diagnosis
1
2016
79
0.030
Why?
Multivariate Analysis
1
2019
1491
0.030
Why?
Stents
1
1999
504
0.030
Why?
Guideline Adherence
1
2019
526
0.030
Why?
Motivational Interviewing
1
2016
101
0.030
Why?
Societies, Medical
1
2018
757
0.030
Why?
Neopterin
1
2014
12
0.030
Why?
Darunavir
1
2014
18
0.030
Why?
Atazanavir Sulfate
1
2014
41
0.030
Why?
Ritonavir
1
2014
73
0.030
Why?
Randomized Controlled Trials as Topic
1
2019
1368
0.030
Why?
Blood Proteins
1
2014
244
0.020
Why?
Transplantation
1
2012
31
0.020
Why?
Inpatients
1
2016
476
0.020
Why?
Smoking
1
2019
1501
0.020
Why?
Rifabutin
1
2011
6
0.020
Why?
Clarithromycin
1
2011
28
0.020
Why?
Ofloxacin
1
2011
24
0.020
Why?
Viremia
1
2012
132
0.020
Why?
Quality of Life
1
2023
2694
0.020
Why?
Receptors, Immunologic
1
2012
216
0.020
Why?
Macaca mulatta
1
2011
150
0.020
Why?
Integrins
1
2011
93
0.020
Why?
RNA, Viral
1
2014
620
0.020
Why?
Practice Patterns, Physicians'
1
2019
1257
0.020
Why?
Data Interpretation, Statistical
1
2012
337
0.020
Why?
Programmed Cell Death 1 Receptor
1
2012
232
0.020
Why?
Hypertension
1
2019
1235
0.020
Why?
Immunocompromised Host
1
2011
199
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2011
754
0.020
Why?
Health Promotion
1
2015
716
0.020
Why?
Blotting, Western
1
2011
1199
0.020
Why?
Neoplasms
1
2002
2450
0.020
Why?
Feces
1
2011
442
0.020
Why?
Protein Binding
1
2014
2121
0.020
Why?
False Negative Reactions
1
2007
52
0.020
Why?
Flow Cytometry
1
2011
1158
0.020
Why?
Lymphocyte Activation
1
2011
1109
0.020
Why?
Cardiovascular Diseases
1
2019
1997
0.020
Why?
Pregnancy
1
2019
6412
0.020
Why?
Gene Expression Profiling
1
2011
1684
0.010
Why?
Genotype
1
2009
1827
0.010
Why?
T-Lymphocytes
1
2012
1935
0.010
Why?
Chemoprevention
1
2004
91
0.010
Why?
China
1
2004
192
0.010
Why?
Infant
1
2016
9005
0.010
Why?
Child, Preschool
1
2016
10499
0.010
Why?
Atovaquone
1
2001
3
0.010
Why?
Reproducibility of Results
1
2009
3081
0.010
Why?
Survival
1
2001
38
0.010
Why?
Ubiquinone
1
2001
28
0.010
Why?
Gene Amplification
1
2001
103
0.010
Why?
Cardiomyopathy, Dilated
1
2003
381
0.010
Why?
Postoperative Complications
2
2003
2475
0.010
Why?
Biomarkers
1
2011
3968
0.010
Why?
Sulfones
1
2000
108
0.010
Why?
Epidural Space
1
1999
12
0.010
Why?
Animals
2
2011
35334
0.010
Why?
Radiotherapy, Adjuvant
1
1999
208
0.010
Why?
Recurrence
1
2001
1011
0.010
Why?
Radiation Injuries
1
1999
135
0.010
Why?
Polymorphism, Genetic
1
2001
636
0.010
Why?
Heart Transplantation
1
2003
722
0.010
Why?
Esophagus
1
1999
250
0.010
Why?
Child
1
2016
20932
0.010
Why?
Molecular Sequence Data
1
2001
2827
0.010
Why?
Esophageal Neoplasms
1
1999
297
0.010
Why?
Follow-Up Studies
1
2003
4891
0.010
Why?
Carcinoma, Squamous Cell
1
1999
628
0.010
Why?
Case-Control Studies
1
2001
3383
0.010
Why?
Angina Pectoris
1
1971
66
0.010
Why?
Tomography, X-Ray Computed
1
1999
2503
0.000
Why?
Coronary Vessels
1
1971
239
0.000
Why?
Aorta
1
1971
407
0.000
Why?
Magnetic Resonance Imaging
1
1999
3392
0.000
Why?
Angiocardiography
1
1971
1
0.000
Why?
Extracorporeal Circulation
1
1971
13
0.000
Why?
Methods
1
1971
63
0.000
Why?
Saphenous Vein
1
1971
32
0.000
Why?
Transplantation, Autologous
1
1971
213
0.000
Why?
Emergencies
1
1971
156
0.000
Why?
Armstrong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)